Showing results (31-40 of 264) with videos related to
Sort By:
Pageof 27
Current Opinion in Infectious Diseases|October 7, 2022
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?Matteo Bassetti, Antonio Vena, Laura Labate, et al.Immunopharmacology and Immunotoxicology|December 3, 2009
Anti-NuMA antibodies in a psoriatic patient: considerations about clinical relevance and effect of infliximab treatmentMarilina Tampoia, Valentina Mastrandrea, Nicoletta Cassano, et al.Archives of Medical Research|September 29, 2021
Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future DirectionsMatteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.Current Opinion in Infectious Diseases|January 4, 2021
Potential role of new-generation antibiotics in acute bacterial skin and skin structure infectionsDaniele R Giacobbe, Laura Labate, Antonio Vena, et al.Expert Opinion on Pharmacotherapy|November 14, 2022
An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months oldMatteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, et al.Expert Opinion on Pharmacotherapy|July 19, 2023
Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenarioMatteo Bassetti, Giorgia Brucci, Antonio Vena, et al.Drugs in Context|September 14, 2019
Challenges and research priorities to progress the impact of antimicrobial stewardshipMatteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, et al.Dermatologic Therapy|November 7, 2009
An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatmentNicoletta Cassano, Valentina Mastrandrea, Michelangelo Vestita, et al.Current Opinion in Infectious Diseases|January 6, 2021
Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indicationsMatteo Bassetti, Laura Labate, Antonio Vena, et al.Drugs in Context|June 7, 2018
How to manage Pseudomonas aeruginosa infectionsMatteo Bassetti, Antonio Vena, Antony Croxatto, et al.Pageof 27